Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review
J Neuroimmune Pharmacol
.
2020 Sep;15(3):349.
doi: 10.1007/s11481-020-09940-9.
Epub 2020 Sep 2.
Authors
Tejas K Patel
1
,
Manish Barvaliya
2
,
Bhavesh D Kevadiya
3
,
Parvati B Patel
4
,
Hira Lal Bhalla
5
Affiliations
1
Department of Pharmacology, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, Uttar Pradesh, 273008, India. dr.tkp2006@yahoo.co.in.
2
Department of Pharmacology, Government Medical College, Bhavnagar, Gujarat, 364001, India.
3
Department of Radiology, Stanford Medicine, Stanford University, Palo Alto, CA, 94304, USA.
4
Department of Pharmacology, GMERS Medical College, Gotri, Vadodara, Gujarat, 390021, India.
5
Department of Pharmacology, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, Uttar Pradesh, 273008, India.
PMID:
32607690
PMCID:
PMC7326306
DOI:
10.1007/s11481-020-09940-9
No abstract available
Publication types
Letter
Comment